Impaired mobilization of CD133 + bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes

Circulation Journal

Volumn 75, Issue 11, 2011, Pages 2635-2641

  Goekmen Turan, R ^a   Hakan Turan, C ^a   Bozdag Turan, Ilkay ^a   Ortak, Jasmin ^a   Akin, Ibrahim ^a   Kische, Stephan ^a   Schneider, Henrik ^a   Kleinfeldt, Tilo ^a   Rehders, Tim C ^a   Rauchhaus, Mathias ^c   Adolph, Esther ^a   Amen, Shwan ^a   Hermann, Tina ^a   Yokus, Sedat ^b   Brehm, Micheal ^b   Steiner, Stephan ^b   Sahin, Kurtulus ^d   Nienaber, Christoph A ^a   Ince, Hueseyin ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Institute for Clinical Research and Statistics   (Germany)

Author keywords

CD133 45 +; Diabetes; Ischemic heart disease; Mobilization

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CD133+ BONE MARROW DERIVED CIRCULATING PROGENITOR CELL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; STEM CELL MOBILIZATION; SYNTAX SCORE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD45; BONE MARROW CELLS; DIABETES COMPLICATIONS; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PEPTIDES; STEM CELLS;

EID: 80054928980     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1284     Document Type: Article

References (42)

1. Luttun A, Carmeliet G, Carmeliet P. Vascular progenitors from biology to treatment. Trends Cardiovasc Med 2002; 12: 88-96.
2. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells, new hope for a broken heart. Circulation 2003; 107: 3093-3100.
3. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
4. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
5. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-2786.
6. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000; 106: 571-578.
7. Vita JA, Treasure CB, Nabel EG, McLenachen JM, Fisch RD, Yeung AC, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497.
8. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, et al. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography): Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999; 33: 1756-1824.
9. + cell determination by flow cytometry. J Hematotherapy 1996; 5: 213-226.
10. + cell counts based on the ISHAGE guidelines: International Society of Hematotherapy and Graft Engineering. Cytometry 1998; 34: 61-70.
11. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
12. Choy JC, Granville DJ, Hunt DW, McManus BM. Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001; 33: 1673-1690.
13. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+) AC133(+) endothelial precursor cells. Circ Res 2001; 88: 167-174.
14. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73: 411-418.
15. Schwartz SM, Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci USA 1976; 73: 651-653.
16. Opden Buijs J, Musters M, Verrips T, Post JA, Braam B, van Riel N. Mathematical modeling of vascular endothelial layer maintenance: The role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol 2004; 287: H2651-H2658.
17. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
18. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
19. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-712.
20. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Döbert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
21. Turan RG, Bozdag-Turan I, Ortak J, Akin I, Kische S, Schneider H, et al. Improvement of cardiac function by intra coronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. Circ J 2011; 75: 683-691.
22. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzales XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
23. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-3112.
24. Kong D, Melo LG, Gnecchi M, Zhang L, Mostosiavsky G, Liew CC, et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004; 110: 2039-2046.
25. Werner N, Priller J, Laufs U, Endres M, Böhm M, Dirnagl U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition. Arterioscler Thromb Vasc Biol 2002; 22: 1567-1572.
26. Werner N, Junk S, Laufs U, Link A, Walenta K, Böhm M, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003; 93: e17-e24.
27. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457-463.
28. Turan RG, Brehm M, Koestering M, Zeus T, Bartsch T, Steiner S, et al. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction. Eur J Clin Invest 2007; 37: 842-851.
29. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
30. Werner N, Nickenig G. Endothelial progenitor cells in health and atherosclerotic disease. Ann Med 2007; 39: 82-90.
31. Turan RG, Brehm M, Köstering M, Bartsch T, Zeus T, Picard F, et al. Effects of exercise training on mobilization of BM-CPCs and migratory capacity as well as LVEF after AMI. Med Klin 2006; 101: 198-201.
32. Brehm M, Picard F, Ebner P, Turan RG, Bölke E, Köstering M, et al. Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction. Eur J Med Res 2009; 14: 393-405.
33. + progenitor cells in patients with stable angina pectoris undergoing percutaneous coronary intervention. Circ J 2010; 74: 1929-1935.
34. Eizawa T, Ikeda U, Murakami Y, Matsui K, Yoshioka T, Takahashi M, et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 2004; 90: 685-686.
35. Kunz GA, Liang G, Cuculi F, Gregg D, Vata KC, Shaw LK, et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 2006; 152: 190-195.
36. Aguilar D, Deswal A, Ramasubbu K, Mann DL, Bozkurt B. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol 2010; 105: 373-377.
37. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99: 2239-2242.
38. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006; 26: 2140-2146.
39. Caballero S, Sengupta N, Afzal A, Chang KH, Li Calzi S, Guberski DL, et al. Vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 2007; 56: 960-967.
40. Park JA, Kwon JG. Could circulating progenitor cell count be a barometer for coronary artery disease progression? Circ J 2010; 74: 1804-1805.
41. Werner C, Kamani CH, Gensch C, Böhm M, Laufs U. The peroxisome proliferator-activated receptor-y agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes J 2000; 56: 2609-2615.
42. Makino H, Okada S, Nagumo A, Sugisawa T, Miyamoto Y, Kishimoto I, et al. Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients. Diabetes Res Clin Pract 2008; 81: 327-330.